References
- Baker, J. M., L. Al-Nakkash, and M. M. Herbst-Kralovetz. 2017. Estrogen-gut microbiome axis: Physiological and clinical implications. Maturitas 103:45–53. September. doi:https://doi.org/10.1016/j.maturitas.2017.06.025. Epub 2017 Jun 23. PMID: 28778332.
- Bender, C. M., J. D. Merriman, A. L. Gentry, G. M. Ahrendt, S. L. Berga, A. M. Brufsky, F. E. Casillo, M. M. Dailey, K. I. Erickson, F. M. Kratofil, et al. 2015. Patterns of change in cognitive function with anastrozole therapy. Cancer 121 (15):2627–36. August 1. doi:https://doi.org/10.1002/cncr.29393. Epub 2015 Apr 23. PMID: 25906766; PMCID: PMC4512875.
- Clarkson, T. B. 2007. NAMS endowed lecture: Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause 14:373–84. doi:https://doi.org/10.1097/GME.0b013e31803c764d.
- Coelingh Bennink, H. J., C. F. Holinka, and E. Diczfalusy. 2008. Estetrol review: Profile and potential clinical applications. Climacteric 11 (Suppl 1):47–58. doi:https://doi.org/10.1080/13697130802073425. PMID: 18464023.
- Gaspard, U., M. Taziaux, M. Mawet, M. Jost, V. Gordenne, H. J. T. Coelingh Bennink, R. A. Lobo, W. H. Utian, and J. M. Foidart. 2020. A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): Part 1. Vasomotor symptoms and overall safety. Menopause 27 (8):848–57. August. doi:https://doi.org/10.1097/GME.0000000000001561. PMID: 32379217; PMCID: PMC7386865.
- Hodis, H. N., and W. J. Mack. 2013a. The timing hypothesis and hormone replacement therapy: A paradigm shift in the primary prevention of coronary heart disease in women. Part 1: Comparison of therapeutic efficacy. Journal of the American Geriatrics Society 61 (6):1005–10. June. doi:https://doi.org/10.1111/jgs.12140. Epub 2013 Feb 15. PMID: 23414520; PMCID: PMC3660423.
- Hodis, H. N., and W. J. Mack. 2013b. The timing hypothesis and hormone replacement therapy: A paradigm shift in the primary prevention of coronary heart disease in women. Part 2: Comparative risks. Journal of the American Geriatrics Society 61 (6):1011–18. June. doi:https://doi.org/10.1111/jgs.12281. Epub 2013 May 20. PMID: 23692449.
- Hodis, H. N., W. J. Mack, V. W. Henderson, D. Shoupe, M. J. Budoff, J. Hwang-Levine, Y. Li, M. Feng, L. Dustin, N. Kono, et al. 2016. Vascular effects of early versus late postmenopausal treatment with estradiol. The New England Journal of Medicine 374:1221–31. doi:https://doi.org/10.1056/NEJMoa1505241.
- Klipping, C., I. Duijkers, M. Mawet, C. Maillard, A. Bastidas, M. Jost, and J. M. Foidart. 2021. Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone. Contraception 103 (4):213–21. April. doi:https://doi.org/10.1016/j.contraception.2021.01.001. Epub 2021 Jan 9. PMID: 33428907.
- Pickar, J. H., T. MacNeil, and K. Ohleth. 2010. SERMs: Progress and future perspectives. Maturitas 67 (2):129–38. October. doi:https://doi.org/10.1016/j.maturitas.2010.05.009. Epub 2010 Jun 26. PMID: 20580502.
- Rocca, W. A., M. M. Mielke, L. Gazzuola Rocca, and E. A. Stewart. 2021. Premature or early bilateral oophorectomy: A 2021 update. Climacteric 24 (5):466–73. October. doi:https://doi.org/10.1080/13697137.2021.1893686. Epub 2021 Mar 15. PMID: 33719814; PMCID: PMC8532166.
- Rossouw, J. E., G. L. Anderson, R. L. Prentice, A. Z. LaCroix, C. Kooperberg, M. L. Stefanick, R. D. Jackson, S. A. Beresford, B. V. Howard, K. C. Johnson, et al.; Writing Group for the Women’s Health Initiative Investigators. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women’s Health Initiative randomized controlled trial. JAMA: The Journal of the American Medical Association 288 (3):321–33. July 17.doi:https://doi.org/10.1001/jama.288.3.321. PMID: 12117397.
- Simpson, E., and R. J. Santen. 2015. Celebrating 75 years of oestradiol. Journal of Molecular Endocrinology 55 (3):T1–20. December. doi:https://doi.org/10.1530/JME-15-0128. Epub 2015 Oct 5. PMID: 26438567.
- Suzuki, S., C. M. Brown, C. D. Dela Cruz, E. Yang, D. Bridwell, and P. M. Wise. 2007. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and anti-inflammatory actions. Proceedings of the National Academy of Sciences 104:6013–18. doi:https://doi.org/10.1073/pnas.0610394104.
- Turner, R. J., and I. J. Kerber. 2017. A theory of eu-estrogenemia: A unifying concept. Menopause 24 (9):1086–97. September. doi:https://doi.org/10.1097/GME.0000000000000895. PMID: 28562489; PMCID: PMC5571883.